Find Academic Supervisors

• Pharmacogenomics
• Pharmacist-led interventions
• Pharmacy education
• +5 more

Dr. Chiao Xin Lim is a Senior Lecturer in the Department of Health and Biomedical Sciences at RMIT University. Her research focuses on pharmacogenomics implementation, culturally competent healthcare interventions, digital health innovation, and pharmacy education. She coordinates third-year undergraduate pharmacy practice courses and supervises research projects addressing medication adherence in culturally diverse populations. Professional roles include General Council member and Education Representative for the Australasian Pharmaceutical Science Association (2023-24) and membership in the Pharmaceutical Society of Australia. Key research interests span asthma self-management in Middle Eastern Arabic-speaking refugees, palliative care pharmacist roles, and educational strategies for cultural competence in health professions. Dr. Lim's teaching innovations include case-based learning for cultural competence and interprofessional simulations between nursing/pharmacy students. She has pioneered validated tools for asthma inhaler technique assessment in Arabic-speaking populations and developed survey instruments for oncology pharmacogenomics education needs. Supervision Focus: Culturally responsive healthcare strategies for cardiovascular, diabetes, and respiratory conditions Key Projects: Pharmacogenomics implementation in oncology, digital health interventions for medication adherence, and policy analysis for asylum seeker health equity Labs/Teams: Actively involved in multidisciplinary research teams addressing healthcare disparities and pharmacist-led interventions. Collaborates with international partners on translational research projects.

David HallidayView profile

Professor

• Computational Neuroscience
• Neural Computing
• Intelligent Systems
• +3 more

Professor David Halliday holds a position at the University of York as a Professor and Chair of the Research Committee. His research focuses on interdisciplinary fields of Computational Neuroscience and Neural Computing, with a particular emphasis on neural networks and neurophysiological signal analysis. He leads the Intelligent Systems and Nano-science Group and maintains an active research profile with over 100 publications. His work integrates theoretical modeling with experimental techniques to investigate topics such as motor control, neural oscillations, and clinical applications of machine learning. David Halliday's academic training includes a BSc and PhD, though specific institutions are not detailed in the provided text. His research interests span computational modeling of neural circuits, development of neuro-inspired algorithms, and application of signal processing techniques to neurological disorders. His homepage at http://www-users.york.ac.uk/~dh20 provides further details, including access to his ResearcherID profile (RID: A-3848-2009). Key research contributions include studies on cortico-muscular coherence in movement disorders, astrocyte-neuron interactions, and fault-tolerant spiking neural networks. His publications demonstrate interdisciplinary collaboration across computational neuroscience, biomedical engineering, and clinical diagnostics. Notably, his work combines experimental neurophysiology with advanced computational methods, such as non-parametric directionality analysis and wavelet-based coherence estimation. Recent studies have addressed clinically relevant topics like gait disturbance in spinal cord injury and biomarker identification in bladder cancer using machine learning approaches.

• Psychiatry
• Clinical Psychology
• Neuroscience
• +5 more

Dr. Rand J. Gruen is an Assistant Clinical Professor in the Department of Psychiatry at Yale School of Medicine. He specializes in psychotherapy and supervises residents in clinical practice. His academic background includes a PhD in Psychology from the University of California, Berkeley (1985), followed by postdoctoral training at Yale School of Medicine (1989). Education: BA, MA, and PhD in Psychology, University of California, Berkeley (1982-1985) Postdoctoral Fellow, Yale University School of Medicine (1989) Research Focus: Dr. Gruen's work spans clinical and neuroscience domains. Key areas include: - Neuropharmacology of GABAergic and dopaminergic systems - Stress neurobiology and its impact on brain function - Alzheimer's disease mechanisms (amyloid-beta pathology) - Psychological aspects of stress appraisal and coping - Psychotherapeutic approaches to depressive disorders Publications Trend: His research demonstrates cross-disciplinary expertise: - Early work (1980s-1990s) focused on neurochemical mechanisms (GABAA receptors, dopamine pathways) - Later studies (2000s) addressed Alzheimer's biomarkers and clinical psychology - Consistent exploration of brain-behavior relationships across development and stress contexts Grants & Advising: No specific grants or advisee names are listed in available records. His clinical supervision role suggests involvement in resident training programs. Labs/Teams: Affiliated with Yale Psychiatry Department research programs, though specific lab affiliations are not detailed in the provided information.

Diana Tavares FerreiraView profile

Assistant Professor

• Cellular and molecular mechanisms of axonal integrity
• RNA transport and regulation
• Computational neuroscience
• +3 more

Diana Tavares Ferreira is an Assistant Professor of Neuroscience at the University of Texas at Dallas (UTD) within the School of Behavioral and Brain Sciences . Her research focuses on understanding cellular and molecular mechanisms underlying axonal integrity in sensory neurons, particularly in neuropathies and neurodegenerative diseases. Education & Training: Postdoctoral Researcher in Neuroscience at UTD (2023) PhD in Neuroscience from the University of Sheffield, UK (2018) PharmD/MS in Pharmaceutical Sciences from the University of Coimbra, Portugal (2013) Research Interests: RNA transport dynamics in distal axons Role of non-coding RNAs (e.g., miRNAs) in sensory neuron function Computational integration of multi-omics data (single-cell, spatial transcriptomics) Mechanisms of axon-soma communication and axonal regeneration Her lab, the Axon Biology and Neuroinformatics Lab , combines experimental and computational approaches to decode how RNA regulation impacts nerve health and disease. Awards & Recognition: Peter J. Dyck Abstract Prize (2022) for diabetic neuropathy research Catalyst Studentship (2016) from the Higher Education Funding Council for England Grants & Funding: Data Core UTD PRECISION Pain Center (National Institute of Neurological Disorders and Stroke, 2022–2027) Dr. Ferreira is currently accepting graduate students and collaborates on projects involving spatial transcriptomics and translational control in chronic pain mechanisms.

Larry FeigView profile

Professor

• Molecular Biology
• Epigenetics
• Stress Physiology
• +3 more

Larry Feig is a Professor in the Department of Developmental, Molecular and Chemical Biology at Tufts University School of Medicine. His research focuses on molecular mechanisms underlying sex-dependent effects of stress across generations, particularly involving Ras-GRF1 and epigenetic inheritance via sperm miRNAs. He holds a PhD from Harvard University and has held faculty positions since 1987. He teaches courses in molecular biology and signal transduction, and has been awarded the Distinguished Faculty Award (2017). Education: PhD in Biological Sciences, Harvard University (1982) MS in Chemistry, Massachusetts Institute of Technology (1976) BS in Chemistry, Columbia University (1974) Research Interests: Feig's lab investigates: Sex-specific stress responses in adolescents Transgenerational epigenetic inheritance via sperm miRNAs Lamarckian inheritance mechanisms in mammals Neuroendocrine regulation of HPA axis Publications Trends: Recent work emphasizes miRNA-mediated transgenerational effects of paternal stress exposure. Key themes include: Role of miR-34c/449 in stress transmission Epigenetic mechanisms in multi-generational behavior Interactions between astrocytes and sperm biology Neurodevelopmental impacts of environmental enrichment Grants & Funding: Active NIH grants include studies on: Sperm miRNAs in trauma transmission (2020-2024) Paternal stress effects across generations (2015-2020) Professional Activities: NIH Study Section reviewer (2019) Member, Tufts Cancer Center (2006-2015) Program Director, Biochemistry Program (2001-2020) Labs/Teams: His lab collaborates on projects involving: Mouse behavioral models Epigenetic analysis techniques 3D tissue models for cancer research

Vijendra SharmaView profile

Professor

• Neuroscience
• Molecular Biology
• Neurodegenerative Diseases
• +3 more

Professor Vijendra Sharma is a faculty member in the Department of Biomedical Sciences at the University of Windsor's Faculty of Science. His research focuses on neurodegenerative diseases, particularly Alzheimer’s, exploring molecular pathways and therapeutic interventions. He has secured grants from the WE-Spark Health Institute’s Igniting Discovery program to advance his work. His research interests span molecular mechanisms of memory, stress response pathways, and translational control in neurological disorders. Sharma’s lab utilizes mouse models and cellular systems to study Alzheimer’s, autism, and epilepsy, with recent emphasis on quinone reductase 2 (QR2) inhibitors and astrocyte functions. His work bridges basic science and clinical outcomes, including studies on obesity-linked lncRNA and alcohol-induced liver injury. His recent publications highlight contributions to understanding ATF4’s role in long-term memory, 4E-BP2-dependent translation in cerebellar Purkinje cells, and p53’s prognostic significance in breast carcinoma. Collaborations and grants underscore his commitment to interdisciplinary research addressing health challenges. Sharma mentors students in neuroscience and molecular biology, though no specific advisees are listed. His research also involves collaborations within the Faculty of Science and beyond, focusing on translational neurobiology and drug development strategies.

• Virology
• Emerging Viral Infections
• Arbovirus Pathogenesis
• +12 more

Barry Rockx is an Assistant Professor in the Department of Virology at Erasmus MC, where he conducts cutting-edge research on emerging and re-emerging RNA viruses. His work focuses on understanding viral pathogenesis, host immune responses, and developing advanced preclinical models to study infections such as SARS-CoV-2, Zika virus, West Nile virus, Usutu virus, and orthohantaviruses. His research interests span virology, immunology, and infectious diseases, with a particular emphasis on arboviruses and neurotropic viruses . He employs human lung xenograft mouse models and fetal organotypic brain slice cultures to investigate infection mechanisms and evaluate potential therapeutics. The recent publications (2024–2025) demonstrate a strong trend in studying vector-borne transmission , neurovirulence , and diagnostic development . His work frequently explores cross-viral comparisons (e.g., Usutu vs. Zika vs. West Nile), highlighting shared and distinct pathogenic mechanisms. Scientific contributions include: Development of a pan-orthohantavirus human lung xenograft model for preclinical testing Investigating mosquito saliva effects on West Nile virus pathogenesis Assessing neurotropism of Usutu and West Nile viruses in human neural tissues Implementing RT-PCR diagnostics for orthohantaviruses in endemic regions Dr. Rockx supervises research work, as indicated by the 'Supervised Work (4)' metric, suggesting mentorship of students or junior scientists. He collaborates widely across institutions and countries, contributing to a robust network in global virology research. There is no mention of formal education, awards, or grants in the provided text, but his publication record and active research profile underscore his significant role in advancing virological science.

Moin SyedView profile

Professor

• Identity Development
• Ethnic Identity
• Racial Identity
• +12 more

Moin Syed is a Professor in the Department of Psychology at the University of Minnesota, Twin Cities, within the College of Liberal Arts. His research centers on identity development, particularly ethnic and racial identity, with a focus on educational disparities, the achievement gap, and the opportunity gap. He actively contributes to the UN Sustainable Development Goals related to quality education and reduced inequalities. Research Interests: His work spans identity development in emerging adulthood, narrative psychology, and the psychological experiences of ethnic minorities. He investigates how cultural, racial, and ethnic identities shape psychological outcomes, academic engagement, and social integration. His research integrates developmental, social, and educational psychology perspectives. The recent publications highlight a strong trend in identity formation, psychometric validation, and social justice issues. Topics include narcissism across racial groups, Islamophobia measurement, identity interventions, and models of racial identity development. His work increasingly emphasizes methodological rigor, open science, and the application of psychological research to address systemic inequities. Scientific Awards: Talle Faculty Research Award, 2019–2020 Advising and Grants: While specific students are not listed, Dr. Syed has served as Principal Investigator (PI) and Co-Investigator (CoI) on multiple significant grants, including those from the National Science Foundation and Simons Foundation. His projects include the North Star STEM Alliance, which supports minority participation in STEM, and research on immigrant narratives for social change. He also led a project on genetic impacts on behavior at the University of Pennsylvania. Labs and Teams: Dr. Syed is part of a collaborative research network focused on identity, equity, and psychological development. He works within interdisciplinary teams addressing educational disparities and social change, particularly through narrative and community-based approaches.

Amparo Acker-PalmerView profile

Professor

• Neurovascular Interface
• Molecular Signaling Pathways
• Vascular Biology
• +4 more

Amparo Acker-Palmer is a Professor at Goethe University Frankfurt's Institute of Cell Biology and Neuroscience, Department of Molecular and Cellular Neurobiology, and holds a Max Planck Fellow position at the MPI for Brain Research since 2014. Her research focuses on the molecular crosstalk between vascular and nervous systems at the neurovascular interface. Her primary research interests include: Neurovascular communication during CNS development Molecular pathways in vessel-nerve crosstalk Vascular roles in synaptic plasticity Ephrin/VEGF receptor signaling mechanisms Neurovascular interface in disease models Analysis of her 51 publications reveals consistent focus on vascular guidance in neural development, receptor crosstalk (particularly EphrinB2/VEGFR2), and neurovascular unit dynamics. Her work spans molecular neuroscience, vascular biology, and developmental neurobiology, with significant contributions to understanding how blood vessels instruct neuronal behavior. Her laboratory utilizes mouse and zebrafish models to investigate these processes, with recent work emphasizing therapeutic implications for neural repair and cancer metastasis.

Mike O. KarlView profile

Professor

• Neurodegeneration
• Retinal Regeneration
• Age-related Macular Degeneration
• +4 more

Prof. Dr. Mike O. Karl serves as Group Leader at the Center for Regenerative Therapies Dresden (CRTD) and the German Center for Neurodegenerative Diseases (DZNE), Technische Universität Dresden, Germany. Research Focus: The Karl Group (MOKALAB) investigates neurodegenerative mechanisms in the human retina, with primary emphasis on age-related macular degeneration (AMD). Utilizing human retinal organoids and stem cell-derived models, they study retinal cell fate regulation, neuronal degeneration, and regenerative potential of Müller glia to develop novel therapeutic strategies for vision restoration. Grants and Training: Research is supported by European and German funding agencies. The group actively recruits PhD students through the Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB) and collaborates with institutional partners for translational research. Laboratory: MOKALAB specializes in advanced 3D retinal organoid development, photoreceptor and Müller glia pathology modeling, and high-resolution imaging of retinal degeneration/regeneration processes.

Ingo SchiesslView profile

Senior Lecturer

• Neuroscience
• Neurovascular Coupling
• Optical Imaging
• +7 more

Ingo Schiessl is a Senior Lecturer in the Division of Neuroscience at the University of Manchester. He holds an ORCID identifier (0000-0001-9599-6194) and has a permanent teaching and research position since 2003. His academic journey includes a BSc and MSc in Physics from the University of Regensburg, followed by medical physics training at a university hospital in Germany. He completed a PhD in neuroscience through a collaboration between the Technical University of Berlin and University College London (UCL). Research Interests: High-resolution functional imaging of neuro-vascular changes in preclinical brain disease models Multi-wavelength optical imaging with electrode and tissue oxygen recordings Key Projects: Neuroinflammation (collaborative research on brain function and translational studies) Brain disorders (focused on Parkinson's disease and stroke mechanisms) Expertise aligns with UN Sustainable Development Goals related to health and well-being. His work involves neurovascular coupling studies, blood-brain barrier mechanisms, and imaging techniques. Recent collaborations span Germany, the UK, and France.

• Cognitive Neuroscience
• Neuropsychology
• Psychobiology
• +3 more

Dr. Francisco Barceló Galindo is a Professor of Psychology at the University of the Balearic Islands , where he has held a position since 2010. He earned his PhD in Psychology from the University of Southampton (1993) and has been a leading figure in Cognitive Neuroscience, Neuropsychology, and Psychobiology. Education: Bachelor’s in Psychology (University of Murcia, 1989), PhD in Psychology (University of Southampton, 1993). His research focuses on human cognition using non-invasive brain activity recording techniques (EEG, MEG) combined with neuropsychological assessments to study attention, memory, and decision-making in healthy individuals and patients with brain damage. He has pioneered computational models based on information theory to quantify cognitive novelty across neural processing levels (sensory, motor, sensorimotor). Analysis of his 15 most recent publications reveals trends in cognitive control mechanisms, task-switching paradigms, prefrontal cortex function, gene-brain interactions (COMT, ANKK1, DAT1), and neuroplasticity in frontal lobe patients. His work spans Q1 journals like Neuron (IF=13.26) and Nature Neuroscience (IF=8.86). Dr. Barceló has secured significant grants, including a €199,065 project from Fundació La Marató de TV3 (2012–2014) and a €69,000 grant from MINECO (2014–2016). He supervises doctoral theses and has directed four completed ones.

• Cell Death
• Ferroptosis
• Redox Signaling
• +5 more

Professor Marcus Conrad serves as Director of the Institute of Metabolism and Cell Death at Helmholtz Munich and holds the Chair of Translational Redox Biology at the Technical University of Munich (TUM) since 2024. His research bridges basic science and translation through the identification and pharmacological targeting of key nodes in cell death and necro-inflammatory processes. Conrad earned his PhD from Helmholtz Zentrum München and Ludwig-Maximilians-University Munich with highest honors (summa cum laude), focusing on selenoproteins in transgenic mice. His academic journey includes research positions at Karolinska Institute, Yamagata University, and leadership roles at Helmholtz Zentrum München before his current directorship. Conrad's research primarily focuses on ferroptosis, a regulated cell death pathway dependent on iron and lipid peroxidation. His work explores how understanding these molecular mechanisms can prevent neurodegenerative diseases and combat cancer. He has made significant contributions to understanding the role of GPX4, FSP1, and other key regulators in ferroptosis, with implications for drug discovery and therapeutic interventions. His publication record shows a strong focus on ferroptosis mechanisms, with recent work exploring novel ferroptosis suppressors, metabolic connections to cell death pathways, and implications for diseases including cancer, neurodegeneration, and kidney disease. His research demonstrates the growing recognition of ferroptosis as a critical pathway with therapeutic potential across multiple disease areas. Galenus-von-Pergamon-Price (2024) European Cell Death Organisation (ECDO) Honorary Award 2024 Multiple ISI Highly Cited Awards (2020-2024) ERC Advanced Grant "IRONDEATH" (2020) m4 Awards for Personalized Medicine (2012, 2017) Conrad has secured significant research funding including an ERC Advanced Grant and coordinates the Deutsche Forschungsgemeinschaft Priority Programme on Ferroptosis (2021-2026) involving 25 centers. He co-founded ROSCUE THERAPEUTICS GmbH in 2020, translating his research into potential therapeutics. Conrad actively mentors researchers through his institute and has organized multiple international conferences on ferroptosis, including EMBO workshops and Cold Spring Harbor Asia conferences. His institute at Helmholtz Munich serves as a hub for ferroptosis research, bringing together experts in redox biology, cell death mechanisms, and translational medicine. Conrad's leadership has positioned his team at the forefront of understanding how regulated cell death pathways can be targeted for therapeutic benefit in multiple disease contexts.

• Translational Regulation
• RNA/Protein Quality Control
• Protein Misfolding
• +5 more

Dr. Andrey L. Karamyshev is an Associate Professor in the Department of Cell Biology and Biochemistry at Texas Tech University Health Sciences Center's School of Medicine. His research focuses on molecular mechanisms of translational regulation and protein quality control, with significant contributions to understanding co-translational protein folding and targeting processes. He leads an active laboratory investigating fundamental cellular pathways with direct implications for human diseases. His primary research interests center on translational regulation mechanisms , particularly the RAPP (Regulation of Aberrant Protein Production) pathway discovered by his team, which monitors nascent chain interactions during translation to prevent defective protein synthesis. His work explores protein misfolding in neurodegenerative diseases like Alzheimer's and Parkinson's, investigating how loss of co-translational interactions leads to pathological aggregation. Additional research areas include ribosome specialization, mRNA quality control, and translational adaptations in parasitic organisms like Leishmania. Analysis of his recent publications (2020-2023) reveals consistent focus on protein quality control pathways , with particular emphasis on the Signal Recognition Particle (SRP) system and its intersections with neurodegenerative disease mechanisms. His work increasingly bridges fundamental molecular biology with therapeutic applications, especially in parasitic diseases and neurodegeneration. Faculty of 1000 recommendation (2014) Faculty of 1000 recommendation (2005) Faculty of 1000 recommendation (2003) Editors' Highlights in Microbiology and Infectious Diseases (Nature Communications, 2023) Dr. Karamyshev actively recruits graduate students to his laboratory, where researchers employ advanced techniques including site-specific photo-crosslinking, iPINCH (identification of Proteins Interacting with Nascent Chains), unnatural amino acid incorporation, and ribosome profiling. His lab has secured research funding supporting investigations into translational regulation mechanisms with potential pharmaceutical applications for neurodegenerative and parasitic diseases. Current projects include elucidating the complete RAPP pathway mechanism and exploring co-translational protein interactions in neurodegenerative disease models. His laboratory maintains active collaborations across Texas Tech University and Texas Tech University Health Sciences Center, particularly with parasitology and neuroscience research groups. The team utilizes specialized methodologies for studying nascent chain interactions both in vitro and in human cell culture systems, with growing focus on translational applications for disease treatment.

• Network Biology
• Computational Systems Medicine
• Proteomics
• +4 more

Jörg Menche holds a full Professor position (Univ.-Prof.) at the University of Vienna, with dual appointments in the Faculty of Mathematics, Department of Mathematics, and Max Perutz Labs, Department of Structural and Computational Biology. His work bridges mathematical modeling and biomedical research through network-based approaches to complex disease mechanisms. Primary research interests include Network Biology, Computational Systems Medicine, and Immunometabolism, with specific focus on proteomic signatures in neuropathic pain, metabolic reprogramming in obesity, and autoimmunity networks. He develops innovative computational tools like VRNetzer for virtual reality network analysis and BioProfiling.jl for high-content imaging data integration, targeting intersections between metabolism, immunity, and environmental exposures. Recent publications (2019-2024) reveal a dominant trend in multi-omics network medicine, particularly in autoimmunity (AutoCore framework), cardiometabolic diseases, and rare genetic disorders. His work demonstrates exceptional translational impact, with multiple papers highlighted by news outlets and patents (e.g., 3 patents referencing 2021 research). While the text indicates involvement in one project (2016) and 13 activities, grant specifics and student mentoring details remain undisclosed. His collaborative network spans immunology, neuroscience, and toxicology, evidenced by co-authorships with clinical and computational teams. Menche operates within Max Perutz Labs, a premier molecular biology research center in Vienna. His team integrates computational biologists, cell biologists, and clinicians to develop network cartography methods for disease module identification, with strong emphasis on virtual reality interfaces and multi-omics validation.